Adaptimmune Therapeutics PLC American...

ADAP

8.24

+0.13

+1.6%

After Hours:

8.24

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 8.19
Prev. Close: 8.11
Low/Hi: 8.12 - 8.71
52-Week: 3.76 - 9.29
Volumes
Equity: 169,519
90-Day Avg: 311,287
Option: 6
90-Day Avg: 43
Volatility
Todays Stock Vol: 85.2
20-Day (HV): 60.8
52-Week (HV): 66.6
30-Day IV: 78.4 +12.5
IV Pct Rank: 23% Subdued
Fundamental
Div. Yield:
Earnings: 13-Mar (Est.)
P/E Ratio:
Market Cap: 759.8 M
Stock Info
Type: Common
ADR:
Sector: Healthcare
Industry: Biotechnology

ADAP Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -878 -20,215 -21,782 -15,414
Change in Working Capital 4,555 1,959 -10,337 14,163
Depreciation Amortization Depletion and Accretion 3,685 1,136 1,046 874
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 1,676 -889 2,634 2,747
Total Cash from Operating Activities 9,038 -18,009 -28,439 2,370
Capital Expenditures -23,079 -8,963 -12,491 -6,921
Other Investing Cash Flow -62,991 -64,221 -10,146 23,880
Total Cash from Investing Activities -86,070 -73,184 -22,637 16,959
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 103,568 41,801 61,397 17
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 103,568 41,801 61,397 17
Exchange Rate Effects 2,223 0 0 -1,498
Net Change in Cash 28,759 -49,392 10,321 17,848
Period Ending 31-Dec-2016
Net Income -71,579
Change in Working Capital 12,496
Depreciation Amortization Depletion and Accretion 3,286
Deferred Taxes 0
Other Non-Cash Activities 7,629
Total Cash from Operating Activities -48,168
Capital Expenditures -12,785
Other Investing Cash Flow 30,540
Total Cash from Investing Activities 17,755
Dividends and Distributions 0
Purchase or Sale of Stock 17
Purchase and Retirement of Debt 0
Other Financing Cash Flow 0
Total Cash from Financing Activities 17
Exchange Rate Effects -5,579
Net Change in Cash -35,975